By integrating data from genomics, transcriptomics, epigenomics, proteomics, and metabolomics, these comprehensive approaches provide insights into the complex molecular landscape of tumors. They aid in identifying biomarkers, unraveling tumor heterogeneity, elucidating therapeutic targets, and advancing personalized treatment strategies for better patient outcomes.
Vision statement: To be a global leader in developing and applying Omics approaches to improve outcomes for brain tumor patients.
Mission statement: We leverage the power of ‘Omics’ by combining patient-centered profiling with novel high-dimensional technologies and analytics to overcome the most pressing challenges in neuro-oncology and revolutionize patient care.
Leadership
- Simon Gregory, Director
- Anoop Patel, Associate Director of Translational Science
- Giselle Lopez, Assistant Director of Molecular Pathology
- David Ashley
- Mike Brown
- Mustafa Khasraw
- Zach Reitman